Welcome to our dedicated page for TIAN RUIXIANG Holdings news (Ticker: $TIRX), a resource for investors and traders seeking the latest updates and insights on TIAN RUIXIANG Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TIAN RUIXIANG Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TIAN RUIXIANG Holdings's position in the market.
TIAN RUIXIANG Holdings announced a 1-for-5 reverse share split of its ordinary shares to regain compliance with Nasdaq rules. Shareholders approved the proposal at an extraordinary general meeting held on May 6, 2024. The Company's class A ordinary shares will begin trading on a post-Share Consolidation basis on May 14, 2024, under the symbol 'TIRX'. The Share Consolidation aims to meet the minimum bid price per share requirement set by Nasdaq.